Balance Sheet Data

AcelRx Pharmaceuticals, Inc. (ACRX)

$0.2096

-0.00 (-0.14%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 60.47105.7166.1442.8912.6658.2761.4764.8568.4172.17
Total Cash (%)
Account Receivables 1.530.400.520.630.160.460.490.520.540.57
Account Receivables (%)
Inventories 0.960.853.291.631.111.581.661.751.851.95
Inventories (%)
Accounts Payable 1.422.071.722.742.121.871.982.082.202.32
Accounts Payable (%)
Capital Expenditure -2.41-0.82-3.47-1.85-1.79-1.89-1.99-2.10-2.22-2.34
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.